HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.

AuthorsH De Leersnyder, J L Bresson, M-C de Blois, J-C Souberbielle, A Mogenet, B Delhotal-Landes, F Salefranque, A Munnich
JournalJournal of medical genetics (J Med Genet) Vol. 40 Issue 1 Pg. 74-8 (Jan 2003) ISSN: 1468-6244 [Electronic] England
PMID12525548 (Publication Type: Clinical Trial, Comparative Study, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic beta-1 Receptor Antagonists
  • Adrenergic beta-Antagonists
  • Receptors, Adrenergic, beta-1
  • Acebutolol
  • Melatonin
Topics
  • Abnormalities, Multiple (blood, drug therapy, genetics)
  • Acebutolol (administration & dosage, therapeutic use)
  • Adolescent
  • Adrenergic beta-1 Receptor Antagonists
  • Adrenergic beta-Antagonists (administration & dosage, therapeutic use)
  • Child
  • Child, Preschool
  • Chronobiology Disorders (blood, drug therapy)
  • Circadian Rhythm (drug effects, physiology)
  • Cohort Studies
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Melatonin (administration & dosage, blood, therapeutic use)
  • Receptors, Adrenergic, beta-1 (physiology)
  • Sleep (drug effects, physiology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: